dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
Published 7 years ago • 496 plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:37
dr. hurvitz on how to navigate her2-targeted therapy in breast cancer
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer
-
1:13
dr. hurvitz on using adcs in her2 breast cancer
-
1:29
dr. hurvitz on standards of care in her2 breast cancer
-
1:35
dr. hurvitz on therapeutics for her2 metastatic breast cancer
-
5:52
anthracyclines for her2-positive early breast cancer
-
1:26
dr. hurvitz on unmet needs in her2 breast cancer
-
1:03
dr. hurvitz on steps to take with her2-positive breast cancer research
-
2:00
dr. hurvitz on treatment hypotheses for tnbc
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
1:17
dr. durand on anthracyclines in treatments for her2 breast cancer
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
1:41
dr. hurvitz on toxicity associated with neratinib in her2 breast cancer
-
1:03
dr. hurvitz on the need for additional research with trastuzumab deruxtecan in her2 breast cancer
-
1:27
dr. hurvitz discusses de-escalation in her2 breast cancer